Germline genetic testing to predict drug response and toxicity in oncology- Reality or fiction?

by Soh, T.I., Yong, W.P.
Published 2014

Identification of gastric cancer biomarkers using 1H nuclear magnetic resonance spectrometry

by Ramachandran G.K., Yong W.P., Yeow C.H.
Published 2018

Recent progress and clinical importance on pharmacogenetics in cancer therapy

by Soh, T.I.P., Yong, W.P., Innocenti, F.
Published 2014

Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy

by Subhash, V.V, Yeo, M.S, Tan, W.L, Yong, W.P
Published 2020

Targeted therapeutics-oriented tumor classification: A paradigm shift

by Quek, T.P.L., Yan, B., Salto-Tellez, M., Yong, W.P.
Published 2012

Knockdown of POLA2 increases gemcitabine resistance in lung cancer cells

by Koh, V, Kwan, H.Y, Tan, W.L, Mah, T.L, Yong, W.P
Published 2020

Effects of Hepatic Impairment on the Pharmacokinetics of Everolimus: A Single-Dose, Open-Label, Parallel-Group Study

by Peveling-Oberhag, J., Zeuzem, S., Yong, W.P., Kunz, T., Paquet, T., Bouillaud, E., Urva, S., Anak, O., Sellami, D., Kobalava, Z.
Published 2014

Impact of sample heterogeneity on methylation analysis

by Loh, M., Liem, N., Lim, P.L., Vaithilingam, A., Cheng, C.L., Salto-Tellez, M., Yong, W.P., Soong, R.
Published 2014

Validation of the functional assessment of cancer therapy-gastric module for the Chinese population

by Zhou H.J., So J.B., Yong W.P., Luo N., Zhu F., Naidoo N., Li S.C., Yeoh K.G.
Published 2018

A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer

by Sundar, R, Rha, S.Y, Yamaue, H, Katsuda, M, Kono, K, Kim, H.S, Kim, C, Mimura, K, Kua, L.-F, Yong, W.P
Published 2020

Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features

by Ang, P.W., Loh, M., Liem, N., Lim, P.L., Grieu, F., Vaithilingam, A., Platell, C., Yong, W.P., Iacopetta, B., Soong, R.
Published 2014

GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells

by Subhash, V.V, Tan, S.H, Tan, W.L, Yeo, M.S, Xie, C, Wong, F.Y, Kiat, Z.Y, Lim, R, Yong, W.P
Published 2020

Disruption of her2-induced pd-l1 inhibits tumor cell immune evasion in patient-derived gastric cancer organoids

by Chakrabarti, J, Koh, V, Steele, N, Hawkins, J, Ito, Y, Merchant, JL, Wang, J, Helmrath, MA, Ahmad, SA, So, JBY, Yong, WP, Zavros, Y
Published 2023

Sequential expression of putative stem cell markers in gastric carcinogenesis

by Wang, T., Ong, C.W., Shi, J., Srivastava, S., Yan, B., Cheng, C.L., Yong, W.P., Chan, S.L., Yeoh, K.G., Iacopetta, B., Salto-Tellez, M.
Published 2014

Anti-tumor efficacy evaluation of a novel monoclonal antibody targeting neutral amino acid transporter ASCT2 using patient-derived xenograft mouse models of gastric cancer

by Kasai N., Sasakawa A., Hosomi K., Poh T.W., Chua B.L., Yong W.P., So J., Chan S.L., Soong R., Kono K., Ishii T., Yamano K.
Published 2018

Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer

by Huellner, M.W., Hennedige, T.P., Winterhalder, R., Zander, T., Venkatesh, S.K., Yong, W.P., Soo, R.A., Seifert, B., Treumann, T.C., Strobel, K., Veit-Haibach, P.
Published 2014

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell l...

by Soo, R.A., Wang, L.Z., Tham, L.S., Yong, W.P., Boyer, M., Lim, H.L., Lee, H.S., Millward, M., Liang, S., Beale, P., Lee, S.C., Goh, B.C.
Published 2014

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell l...

by Soo, R.A., Wang, L.Z., Tham, L.S., Yong, W.P., Lim, H.L., Lee, S.C., Goh, B.C., Lee, H.S, Boyer, M., Millward, M., Beale, P., Liang, S.
Published 2011

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A biomarker evaluation from the AVAGAST randomized phase III trial

by Van Cutsem, E., De Haas, S., Kang, Y.-K., Ohtsu, A., Tebbutt, N.C., Xu, J.M., Yong, W.P., Langer, B., Delmar, P., Scherer, S.J., Shah, M.A.
Published 2014

Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy

by Limviphuvadh, V, Tan, C.S, Konishi, F, Jenjaroenpun, P, Xiang, J.S, Kremenska, Y, Mu, Y.S, Syn, N, Lee, S.C, Soo, R.A, Eisenhaber, F, Maurer-Stroh, S, Yong, W.P
Published 2020